Difference between revisions of "Team:CPU CHINA"
Ser Archer (Talk | contribs) |
Ser Archer (Talk | contribs) |
||
| Line 120: | Line 120: | ||
A gene therapy strategy to traget hepatocellular carcinoma based on conditional RNA interference | A gene therapy strategy to traget hepatocellular carcinoma based on conditional RNA interference | ||
</div> --> | </div> --> | ||
| − | <h1>A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1> | + | <h1 style="position:absolute;width:90%;margin-left:5%;top:16%;">A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference</h1> |
<!-- *****************************************马车动画*********************************************--> | <!-- *****************************************马车动画*********************************************--> | ||
<video id="home-video" style="position:absolute;width:90%;margin-left:5%;top:11%;z-index:100;display:none;" controls="controls" loop="false" preload="preload"> | <video id="home-video" style="position:absolute;width:90%;margin-left:5%;top:11%;z-index:100;display:none;" controls="controls" loop="false" preload="preload"> | ||
| Line 138: | Line 138: | ||
</div> | </div> | ||
</div> | </div> | ||
| − | <div id="words" style="position:relative;display:none;width: | + | <div id="words" style="position:relative;display:none;width:80%;top:69%;margin-left:10%;font-size:2.5rem;line-height:2.5;"> |
MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application. | MicroRNA(miRNA) is a short non-coding RNA, which has the ability to target mRNA and medicate its degradation to downgrade gene expression at transcription level. This mediation effect is called post-transcriptional gene silencing (PTGS, which is also know as RNA interference). RNA interference(RNAi) has proved its potential as gene therapy. The mature miRNA are cleaved from pri-miRNA which gives us possibility to make it conditional. An “AND” gate system based on specific promoters and RNA-dependent RNA polymerase(RdRp) was designed to avoid undesirable effects due to low selectivity. Together, they formed our conditional RNA gene therapy. This year, CPU_CHINA is focusing on hepatocellular carcinoma (HCC). But significantly, the promoters and the target here can be replaced with other disease-specific promoters and target, in gene therapy for the corresponding diseases which enables our project to be a remarkable novel application. | ||
</div> | </div> | ||
Revision as of 02:01, 18 October 2018
A gene therapy strategy to target hepatocellular carcinoma based on conditional RNA interference
